| Patient | Samuel Johnson |
|---|---|
| Date of birth | 1709-09-18 |
| Identifiers | MRN HR-EN008-SYN-TD; SSN (made up) 000-08-7139 |
| Document date | 1765-09-28 |
| Author | Catriona Bell, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Six-month review of depression and tics. [S]
Mr. Johnson returns six months after his first visit and four weeks after his back strain, which settled within a week. His mood is good: he has finished a large part of his book and is back among his friends every day. Night sweats are less. He finished the eight sessions of behavioral therapy for tics in the summer and still uses the competing responses when he wants to; he says the remaining tics bother other people more than they bother him. His fecal immunochemical test and HIV test from the preventive visit were negative. [S]
| Element | Detail |
|---|---|
| Sertraline | 100 mg daily |
| Mood | PHQ-9 4; GAD-7 5 |
| Tics | Behavioral therapy completed |
| Back | Resolved |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Night sweats much less; no weight change |
| Musculoskeletal | Negative | No back pain |
| Neurological | Positive | Tics present but less frequent |
| Psychiatric | Negative | Mood good; no thoughts of suicide or self-harm |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Sertraline 50 mg oral tablet, one tablet by mouth once daily | One tablet by mouth once daily in the morning | Oral route | 1765-04-06 to 1765-05-18 | completed | S |
| Sertraline 100 mg oral tablet, one tablet by mouth once daily | One tablet by mouth once daily in the morning | Oral route | 1765-05-18 | active | S |
| Ibuprofen 400 mg oral tablet, one tablet by mouth three times daily with food for five days | One tablet by mouth three times daily with food for five days | Oral route | 1765-08-31 to 1765-09-05 | completed | S |
| Omeprazole 20 mg delayed-release oral capsule, one capsule by mouth daily while taking ibuprofen | One capsule by mouth daily before breakfast for five days | Oral route | 1765-08-31 to 1765-09-05 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1765-09-28 | Body height | 183 | cm | S |
| 1765-09-28 | Body weight | 98.8 | kg | S |
| 1765-09-28 | Body mass index (BMI) [Ratio] | 29.5 | kg/m2 | S |
| 1765-09-28 | Systolic blood pressure | 122 | mm[Hg] | S |
| 1765-09-28 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1765-09-28 | Heart rate | 74 | /min | S |
| 1765-09-28 | Respiratory rate | 14 | /min | S |
| 1765-09-28 | Body temperature | 36.6 | Cel | S |
| 1765-09-28 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1765-09-28 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S | ||
| 1765-09-28 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 5 | {score} | S |
Vital signs recorded on 1765-09-28; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 122/76, pulse 74 |
| Neurological | Occasional head-turning tics and soft sounds |
| Psychiatric | Euthymic, expansive in conversation, logical |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Major depressive disorder, recurrent, severe, without psychotic features: low mood, loss of interest, poor sleep, guilt, and withdrawal from company for about three months on a background of depression that never fully lifted after a severe episode last year; first episode at about twenty; synthetic modern episode linked to his documented melancholy | active | confirmed | F33.2 | S — Synthetic modern diagnosis by DSM-5 criteria; the record makes no claim about his real mental health. |
| Motor and vocal tics since childhood, with ritual counting and stepping behaviors, never formally diagnosed; neurology evaluation requested | resolved | confirmed | F95.9 | S — Synthetic presenting concern anchored to the documented tics; superseded by the diagnosis at the neurology consultation. |
| Tourette syndrome: multiple motor tics and vocal tics since childhood, with premonitory urges, brief suppressibility, and tic-related obsessive-compulsive symptoms (counting, evening-up, and threshold rituals); synthetic modern diagnosis by DSM-5 criteria at the neurology consultation, linked to the documented tics and to the retrospective diagnosis | active | confirmed | F95.2 | S — Synthetic modern diagnosis; the retrospective historical diagnosis is graded R and is not asserted as fact. |
| Blindness of the left eye since early childhood after scrofula (tuberculous cervical lymphadenitis), with old scars of the neck and face; right eye myopic, corrected to normal; synthetic modern coding linked to his documented loss of sight in one eye | active | confirmed | H54.42 | S — Synthetic modern coding; the source does not say which eye, so the left is a synthetic choice. |
| Acute low back strain after lifting boxes of books, without radicular symptoms or red flags; treated with heat, activity, and a short course of ibuprofen with stomach protection; resolved | resolved | confirmed | S39.012A | S — Synthetic acute problem; not a historical claim. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Depression measure (PHQ-9) | At baseline and at least monthly during acute treatment; every 2 to 4 weeks in continuation | Completed today | 4: remission |
| Medication safety | Sertraline adherence and adverse effects | Every visit in the acute phase; reassess at 2 weeks after starting and after each dose change | Completed today | Adherent; night sweats lessening |
| Medication safety | Interaction review (serotonergic drugs; NSAIDs and anticoagulants with an SSRI) | At the start and with any new medicine | Completed today | The ibuprofen and omeprazole course after the back strain is finished; no other medicines |
| Survey | Suicide-risk review (PHQ-9 item 9 and structured questions since the last visit), safety plan, and the 988 Suicide & Crisis Lifeline | Every visit | Completed today | No thoughts of suicide or self-harm |
| Referral | Psychotherapy (cognitive behavioral therapy with behavioral activation) | Offer to all with moderate or severe depression | Completed today | Monthly |
| Survey | Anxiety measure (GAD-7) | At baseline and with PHQ-9 reviews | Completed today | 5, from 12 |
| Survey | Tic severity (Yale Global Tic Severity Scale, recorded in the note; no LOINC code is used) | At diagnosis and periodically to judge the need for and response to treatment | Completed today | Total tic score 22; impairment 10 |
| Referral | Comprehensive Behavioral Intervention for Tics | Offer as an initial treatment option | Completed today | Eight sessions completed in the summer |
| Medication safety | Tic-suppressing medication (alpha-2 agonist, aripiprazole, or other) | When tics cause impairment that behavioral therapy does not relieve | Not indicated | Tics manageable without medicine |
| Self-management | Zoster, hepatitis B, and influenza vaccines | Per the adult schedule | Completed today | Zoster dose 2, hepatitis B dose 2, and influenza vaccine given today |
Goal progress:
Immunizations given today: Recombinant zoster vaccine, dose 2 of 2; Hepatitis B vaccine (HepB-CpG), dose 2 of 2; Influenza vaccine, 1765-1766 season [S]
Guideline basis: Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders (Pringsheim T, et al. Neurology 2019;92(19):896-906) (2019); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); Adult Immunization Schedule by Medical Condition and Other Indication (2026)
Follow-up: Review in three months with PHQ-9. Neurology as needed. [S]